Merck Manuals to Collaborate with Microsoft to Integrate Medical Information Resources into Healthcare Agent Service in Microsoft Copilot Studio [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
professional medical reference into healthcare agent service in Microsoft Copilot Studio. This exciting initiative harnesses the power of Generative AI (GenAI) to provide clinicians with trusted, comprehensive, and evidence-based medical content at the point of care. The Merck Manuals is proud to be an independent (non-government) medical information resource integrated into this platform. This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio. This integration empowers healthcare technology developers to create generative AI-driven healthcare agents that leverage this high-value content to grant clinicians immediate access to vital medical information. "Clinicians and healthcare organizations worldwide depend on the Merck Manuals and MSD Manuals for accurate and reliable answers to their clinical questions," stated Dr. Sandy Falk , Editor-in-Chief
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for AmericansBusiness Wire
- Merck (MRK)'s CEO Has a “Better Hand,” Says Jim Cramer [Yahoo! Finance]Yahoo! Finance
- Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case [Seeking Alpha]Seeking Alpha
- Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $130.00 price target on the stock, up previously from $82.00.MarketBeat
- Pfizer, Astellas post late-stage trial win for Padcev in bladder cancer with Merck's Keytruda [Seeking Alpha]Seeking Alpha
MRK
Earnings
- 10/30/25 - Beat
MRK
Sec Filings
- 12/4/25 - Form 8-K
- 12/3/25 - Form 424B5
- 12/2/25 - Form FWP
- MRK's page on the SEC website